Nos publications


Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study.

Mulkay JP, Bourgeois S, Lasser L, De Galocsy C, Tomasovic S, Horsmans Y, Van Vlierberghe H; Belgian PROPHESYS investigators. Acta Gastroenterol Belg. 2014 Mar;77(1):30-40.

Voir l’article

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.

De Vos M, Louis EJ, Jahnsen J, Vandervoort JG, Noman M, Dewit O, Dʼhaens GR, Franchimont D, Baert FJ, Torp RA, Henriksen M, Potvin PM, Van Hootegem PP, HindryckxPM, Moreels TG, Collard A, Karlsen LN, Kittang E, Lambrecht G, Grimstad T, Koch J, Lygren I, Coche JC, Mana F, Van Gossum A, Belaiche J, Cool MR, Fontaine F, Maisin JM, Muls V, Neuville B, Staessen DA, Van Assche GA, de Lange T, Solberg IC, Vander Cruyssen BJ, Vermeire SA. Inflamm Bowel Dis. 2013 Sep;19(10):2111-7.

Voir l’article

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.

Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups. Ann Oncol. 2013 Sep;24(9):2342-9. doi: 10.1093/annonc/mdt231. Epub 2013 Jul 12.

Voir l’article

Profile of pediatric Crohn’s disease in Belgium.

De Greef E, Mahachie John JM, Hoffman I, Smets F, Van Biervliet S, Scaillon M, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, Peeters H, Baert F, D’Haens G, Rahier JF, Etienne I, Bauraind O, Van Gossum A, Vermeire S, Fontaine F, Muls V, Louis E, Van de Mierop F, Coche JC, Van Steen K, Veereman G; IBD working group of the Belgian Society of Pediatric Gastroenterology, Hepatology and Nutrition (BeSPGHAN); Belgian IBD Research and Development. J Crohns Colitis. 2013 Dec 1;7(11):e588-98. doi: 10.1016/j.crohns.2013.04.016. Epub 2013 May 9.

Voir l’article

Systematic pancreatic stenting after endoscopic snare papillectomy may reduce the risk of postinterventional pancreatitis.

Napoléon B, Alvarez-Sanchez MV, Leclercq P, Mion F, Pialat J, Gincul R, Ribeiro D, Cambou M, Lefort C, Rodríguez-Girondo M, Scoazec JY. Surg Endosc. 2013 Sep;27(9):3377-87. doi: 10.1007/s00464-013-2920-9. Epub 2013 Apr 3.

Voir l’article

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.

Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16.

Voir l’article

Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study.

Focan C, Kreutz F, Graas MP, Longrée L, Focan-Henrard D, Demolin G, Moeneclaey N. Pathol Biol (Paris). 2013 Apr;61(2):e27-31. doi: 10.1016/j.patbio.2010.12.005. Epub 2012 Oct 25.

Voir l’article

Chronotherapy with 5-fluorouracil folinic acid and oxaliplatin delivered over 48 hours every second week in colorectal cancer. The CHC-Liège experience (Belgium).

Focan C, Demolin G, Kreutz F, Graas MP, Longrée L, Matus G, Moeneclaey N, Focan-Henrard D. Pathol Biol (Paris). 2013 Oct;61(5):e71-4. doi: 10.1016/j.patbio.2011.02.002. Epub 2012 Oct 22. French.

Voir l’article

Three-year results of a multicenter prospective study of transoral incisionless fundoplication.

Muls V, Eckardt AJ, Marchese M, Bastens B, Buset M, Devière J, Louis H, Rajan A, Daniel MA, Costamagna G. Surg Innov. 2013 Aug;20(4):321-30. doi: 10.1177/1553350612459275. Epub 2012 Sep 11.

Voir l’article

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients.

Baert F, Glorieus E, Reenaers C, D’Haens G, Peeters H, Franchimont D, Dewit O, Caenepeel P, Louis E, Van Assche G; BIRD (Belgian IBD Research and Development). J Crohns Colitis. 2013 Mar;7(2):154-60. doi: 10.1016/j.crohns.2012.03.018. Epub 2012 Apr 24

Voir l’article

Dosage de l’amoxicilline/acide clavulanique par LC-MS/MS dans le plasma et les kystes pancréatiques: étude pharmacocinétique de distribution.

Xuereb F, Leclercq P, Legeron R, Zaoui E, Servant V, Saux M, Napoleon B, Breilh D. Le Pharmacien Hospitalier et Clinicien. 2012 Feb;47(Supp1):S72.

Voir l’article

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.

De Vos M, Dewit O, D’Haens G, Baert F, Fontaine F, Vermeire S, Franchimont D, Moreels T, Staessen D, Terriere L, Vander Cruyssen B, Louis E; behalf of BIRD. J Crohns Colitis. 2012 Jun;6(5):557-62. doi: 10.1016/j.crohns.2011.11.002. Epub 2011 Dec 11

Voir l’article

Familial adenomatous polyposis: clinical presentation, detection and surveillance.

Laurent S, Franchimont D, Coppens JP, Leunen K, Macken L, Peeters M, Plomteux O, Polus M, Poppe B, Sempoux C, Tejpar S, Van Den Eynde M, Van Gossum A, Vannoote J, Kartheuser A, Van Cutsem E. Acta Gastroenterol Belg. 2011 Sep;74(3):415-20. Review.

Voir l’article

Hepatitis C of genotype 2: the role of medical invasive exams.

Putzeys V, Gérard C, Bastens B, Wain E, Bataille C, Defrance P, Belaiche J, Delwaide J, Belaiche J, Delwaide J, de Roover A, Detry O, Gérard C, Honoré P, Maggipinto G, Rentier B, Vaira D; Groupe Liégeois d’Etude des Virus Hépatotropes. Acta Gastroenterol Belg. 2011 Jun;74(2):277-80.

Voir l’article

High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.

Francque S, De Maeght S, Adler M, Deltenre P, de Galocsy C, Orlent H, Van Steenbergen W, Bastens B, Wain E, Langlet P, Lasser L, Verlinden W, Van Marck E, Henrion J; Steering Committee of the Belgian Association for the Study of the Liver. Acta Gastroenterol Belg. 2011 Mar;74(1):9-16.

Voir l’article